Verrica Pharmaceuticals
CompanyUnited StatesFounded 2013
Verrica Pharmaceuticals develops one asset, approved (cantharidin in Molluscum Contagiosum). Mostly small molecule; based in the United States, founded in 2013.
- 1
- Asset
- Furthest stage
- Approved
- Raised
- $123M
- 2
- Trials
- 1
- Signal
Pipeline
1Topical cellular vesicant causing blistering of the skin
Approved, Small molecule, Molluscum Contagiosum, common wart (Phase 3)
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials2
- Funding rounds and grants7
- People10
- Signals3
- Similar companies2